Neurodevelopment Outcomes in Very-Low-Birth-Weight Infants with Metabolic Bone Disease at 2 Years of Age

• Hauptverfasser: Yu-Wen Chen (Verfasst von), Yu-Jun Chang (Verfasst von), Lih-Ju Chen (Verfasst von), Cheng-Han Lee (Verfasst von), Chien-Chou Hsiao (Verfasst von), Jia-Yuh Chen (Verfasst von), Hsiao-Neng Chen (Verfasst von)
• Format: Buch
• Veröffentlicht: MDPI AG, 2024-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Metabolic bone disease (MBD) predominantly affects preterm infants, particularly very-low-birth-weight (VLBW) infants weighing <1500 g. However, there are limited reports on MBD and neurodevelopmental outcomes. This study aimed to analyze the risk factors for MBD and understand its impact on neur...